Evidence map›Paper›PMID 32592135›Full record

ArticleInfection2020

Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient.

Deborah Eshagh, Khadija Benali, Antoine Dossier, Marie Paule Chauveheid, Diane Rouzaud, Tiphaine Goulenok, Thomas Papo, Karim Sacre

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Deborah EshaghAssistance Publique Hôpitaux de Paris, Département de Médecine Interne, Hôpital Bichat-Claude Bernard, Université de Paris, 46 rue Henri Huchard, 75018, Paris, France.
Khadija BenaliAssistance Publique Hôpitaux de Paris, Département de Médecine Nucléaire, Hôpital Bichat-Claude Bernard, Université de Paris, Paris, France.
Antoine DossierAssistance Publique Hôpitaux de Paris, Département de Médecine Interne, Hôpital Bichat-Claude Bernard, Université de Paris, 46 rue Henri Huchard, 75018, Paris, France.
Marie Paule ChauveheidAssistance Publique Hôpitaux de Paris, Département de Médecine Interne, Hôpital Bichat-Claude Bernard, Université de Paris, 46 rue Henri Huchard, 75018, Paris, France.
Diane RouzaudAssistance Publique Hôpitaux de Paris, Département de Médecine Interne, Hôpital Bichat-Claude Bernard, Université de Paris, 46 rue Henri Huchard, 75018, Paris, France.
Tiphaine GoulenokAssistance Publique Hôpitaux de Paris, Département de Médecine Interne, Hôpital Bichat-Claude Bernard, Université de Paris, 46 rue Henri Huchard, 75018, Paris, France.
Thomas PapoAssistance Publique Hôpitaux de Paris, Département de Médecine Interne, Hôpital Bichat-Claude Bernard, Université de Paris, 46 rue Henri Huchard, 75018, Paris, France.
Karim SacreAssistance Publique Hôpitaux de Paris, Département de Médecine Interne, Hôpital Bichat-Claude Bernard, Université de Paris, 46 rue Henri Huchard, 75018, Paris, France. karim.sacre@aphp.fr.ORCID http://orcid.org/0000-0002-6544-234X
Université Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In non-human immunodeficiency virus (HIV)-infected patients, tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) is unusual. The management of corticosteroids-refractory IRIS is unclear. We report on infliximab efficacy for treatment of corticosteroid-resistant TB-IRIS occurring in an immunocompetent patient.

Indexed as

Drug Resistance, BacterialAdrenal Cortex HormonesAntitubercular AgentsFemaleFranceHumansImmune Reconstitution Inflammatory SyndromeImmunocompromised HostInfliximabMiddle AgedTuberculosisAdrenal Cortex HormonesAntitubercular AgentsInfliximabImmune reconstitution inflammatory syndromeInfliximabTuberculosis

Identifiers

PMID32592135
OpenAlexW3037027328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.